← Back to Analyst Consensus 
FN Buy
Fabrinet
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 2, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | Susquehanna | maintain | Positive → Positive | — | 55% |
| Oct 15, 2026 | B. Riley Securities | maintain | Neutral → Neutral | — | 55% |
| Aug 20, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Aug 18, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Aug 18, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Aug 18, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Aug 18, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jul 22, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| May 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 5, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| May 5, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 5, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Apr 16, 2026 | JP Morgan | downgrade | Overweight → Neutral | — | 54% |
| Mar 3, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Feb 3, 2026 | B. Riley Securities | maintain | Neutral → Neutral | $452 | 55% |
| Feb 3, 2026 | Barclays | maintain | Overweight → Overweight | $548 | 53% |
| Feb 3, 2026 | Rosenblatt | maintain | Buy → Buy | $550 | 55% |
| Feb 3, 2026 | Needham | reiterate | Buy → Buy | $540 | 50% |
| Jan 22, 2026 | Susquehanna | maintain | Positive → Positive | $570 | 55% |
| Jan 14, 2026 | Barclays | upgrade | Equal-Weight → Overweight | $537 | 53% |
| Dec 15, 2025 | Susquehanna | initiate | — → Positive | $550 | 55% |
| Nov 5, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $499 | 53% |
| Nov 4, 2025 | JP Morgan | maintain | Overweight → Overweight | $530 | 54% |
| Nov 4, 2025 | Rosenblatt | maintain | Buy → Buy | $550 | 55% |
| Nov 4, 2025 | Needham | maintain | Buy → Buy | $540 | 50% |
| Oct 16, 2025 | JP Morgan | maintain | Overweight → Overweight | $430 | 54% |
| Oct 2, 2025 | Rosenblatt | maintain | Buy → Buy | $425 | 55% |
| Aug 25, 2025 | JP Morgan | upgrade | Neutral → Overweight | $345 | 54% |
| Aug 19, 2025 | B. Riley Securities | maintain | Neutral → Neutral | $220 | 55% |
| Aug 19, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $329 | 53% |
| Aug 19, 2025 | Rosenblatt | maintain | Buy → Buy | $360 | 55% |
| Aug 19, 2025 | Needham | reiterate | Buy → Buy | $350 | 50% |
| Jul 17, 2025 | JP Morgan | maintain | Neutral → Neutral | $318 | 54% |
| Jul 8, 2025 | Wolfe Research | initiate | — → Peer Perform | $0 | 53% |
| Jun 12, 2025 | Rosenblatt | maintain | Buy → Buy | $290 | 55% |
| May 6, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $234 | 53% |
| May 6, 2025 | JP Morgan | maintain | Neutral → Neutral | $235 | 54% |
| May 6, 2025 | Needham | reiterate | Buy → Buy | $280 | 50% |
| May 6, 2025 | Rosenblatt | maintain | Buy → Buy | $250 | 55% |
| May 6, 2025 | B. Riley Securities | maintain | Neutral → Neutral | $184 | 55% |
| Apr 22, 2025 | Rosenblatt | maintain | Buy → Buy | $230 | 55% |
| Apr 17, 2025 | JP Morgan | maintain | Neutral → Neutral | $220 | 54% |
| Apr 4, 2025 | B. Riley Securities | upgrade | Sell → Neutral | $176 | 55% |
| Mar 17, 2025 | Needham | reiterate | Buy → Buy | $280 | 50% |
| Mar 14, 2025 | Rosenblatt | maintain | Buy → Buy | $285 | 55% |
| Feb 4, 2025 | JP Morgan | maintain | Neutral → Neutral | $265 | 54% |
| Feb 4, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $245 | 53% |
| Feb 4, 2025 | Rosenblatt | maintain | Buy → Buy | $285 | 55% |
| Feb 4, 2025 | Needham | reiterate | Buy → Buy | $280 | 50% |
| Nov 20, 2024 | B. Riley Securities | downgrade | Neutral → Sell | $178 | 55% |
Price Target Trend
Apr 20, 2026 Latest: $687.78 Oct 25, 2026
EPS Estimates
+1y $21.94
Lo: $20.05 Hi: $24.50
8 analysts ▲4
+1q $4.43
Lo: $4.32 Hi: $4.52
9 analysts ▲7
0y $18.23
Lo: $17.48 Hi: $19.20
9 analysts ▲1
0q $4.19
Lo: $4.16 Hi: $4.20
9 analysts ▲7
Cross-Platform Signals
No cross-platform signals in the last 90 days